NCT04490460View on ClinicalTrials.gov

Effects on Glycemic Control of WBF-0031 in Subjects With Abnormal Glucose Tolerance

NAUnknownINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

February 1, 2021

Study Completion Date

February 28, 2021

Conditions

Abnormal Glucose Tolerance

Interventions

DIETARY_SUPPLEMENT

WBF-0031

Medical food formulation WBF-0031

Trial Locations (1)

97703

Diabetes and Obesity Care, Bend

Sponsors

Collaborators (1)

Pendulum Therapeutics

All Listed Sponsors

collaborator

Pendulum Therapeutics

INDUSTRY

lead

Eden Miller

INDUSTRY